-
EP3752616
Procédure d'examen
Extrait du Registre européen des brevets
EP Présentation générale: EP3752616
| EP3752616 - COMPOSITIONS ET MÉTHODES POUR L'ÉDITION GÉNIQUE PAR CIBLAGE DU FIBRINOGÈNE-ALPHA [Cliquez sur ce lien avec le bouton droit de la souris pour le conserver dans vos signets] | Statut | La requête en examen a été présentée Statut actualisé le 20.11.2020 Base de données mise à jour au 04.11.2024 | |
| Précédent | La publication internationale a été faite Statut actualisé le 24.08.2019 | ||
| Précédent | inconnu Statut actualisé le 30.03.2019 | Dernier événement Tooltip | 27.02.2024 | Nouvelle entrée: taxe annuelle payée | Demandeur(s) | Pour tous les Etats désignés CRISPR Therapeutics AG Baarerstrasse 14 6300 Zug / CH | Pour tous les Etats désignés Bayer HealthCare LLC 100 Bayer Boulevard Whippany, NJ 07981 / US | [2020/52] | Inventeur(s) | 01 /
BROOKS, Alan, Richard c/o Casebia Therapeutics Limited Liability Partnership 455 Mission Bay Boulevard South San Francisco, CA 94158 / US | 02 /
VO, Karen c/o Casebia Therapeutics Limited Liability Partnership 455 Mission Bay Boulevard South San Francisco, CA 94158 / US | [2020/52] | Mandataire(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2020/52] | Numéro de la demande, date de dépôt | 19712058.7 | 15.02.2019 | [2020/52] | WO2019US18361 | Numéro de priorité, date | US201862710415P | 16.02.2018 Format original publié: US 201862710415 P | [2020/52] | Langue de dépôt | EN | Langue de la procédure | EN | Publication | Type: | A1 Demande avec rapport de recherche | N°: | WO2019161310 | Date: | 22.08.2019 | Langue: | EN | [2019/34] | Type: | A1 Demande avec rapport de recherche | N°: | EP3752616 | Date: | 23.12.2020 | Langue: | EN | La demande publiée par l'OMPI le 22.08.2019, dans une des langues officielles de l'OEB, remplace la publication de la demande de brevet européen. | [2020/52] | Rapport(s) de recherche | Rapport de recherche internationale - publié le: | EP | 22.08.2019 | Classification | IPC: | C12N15/113, A61K48/00, C12N15/90 | [2020/52] | CPC: |
C12N15/113 (EP,US);
A61K48/0008 (EP);
A61K48/005 (EP);
C07K14/75 (EP);
C07K14/755 (EP,US);
C12N15/86 (US);
C12N15/907 (EP,US);
C12N9/22 (US);
C12N2310/20 (EP,US);
C12Y301/00 (US)
(-)
| Etats contractants désignés | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/52] | Etats autorisant l'extension | BA | 12.09.2020 | ME | 12.09.2020 | État(s) autorisant la validation | KH | 12.09.2020 | MA | 12.09.2020 | MD | 12.09.2020 | TN | 12.09.2020 | Titre | Allemand: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR GENEDITIERUNG DURCH TARGETING VON FIBRINOGEN-ALPHA | [2020/52] | Anglais: | COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING FIBRINOGEN-ALPHA | [2020/52] | Français: | COMPOSITIONS ET MÉTHODES POUR L'ÉDITION GÉNIQUE PAR CIBLAGE DU FIBRINOGÈNE-ALPHA | [2020/52] | Entrée dans la phase régionale | 12.09.2020 | Taxe nationale de base payée | 12.09.2020 | Taxe(s) de désignation payée(s) | 12.09.2020 | Taxe d'examen payée | Procédure dexamen | 12.09.2020 | Requête en examen déposée [2020/52] | 12.09.2020 | Date à laquelle la division d’examen est devenue compétente | 06.04.2021 | Modification par le demandeur (revendications et/ou déscription) | Taxes payées | Taxe annuelle | 25.02.2021 | Taxe annuelle Année du brevet 03 | 25.02.2022 | Taxe annuelle Année du brevet 04 | 27.02.2023 | Taxe annuelle Année du brevet 05 | 27.02.2024 | Taxe annuelle Année du brevet 06 |
| Dérogation à la compétence Tooltip exclusive de la juridiction unifiée du brevet | Voir le Registre de la juridiction unifiée du brevet pour les données relatives à la dérogation | ||
| La juridiction unifiée du brevet assume l'entière responsabilité de l'exactitude, de l'exhaustivité et de la qualité des données présentées sous le lien fourni. | Cité dans | Recherche internationale | [XA]WO2016011080 (UNIV CALIFORNIA [US]) [X] 65-68 * claims 50-54; sequences 62668, 62675 * [A] 1-64,69-73; | [XA]WO2017074526 (SANGAMO BIOSCIENCES INC [US]) [X] 65,69-73 * figures 10-14 * * the whole document * [A] 1-64,66-68; | [XA]WO2015089077 (SANGAMO BIOSCIENCES INC [US]) [X] 65,69-73 * figure 2 * * the whole document * [A] 1-64,66-68; | [XAI] - T. O. AUER ET AL, "Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair", GENOME RESEARCH, US, (20131031), vol. 24, no. 1, doi:10.1101/gr.161638.113, ISSN 1088-9051, pages 142 - 153, XP055237091 [X] 65,69,70 * figure 1 * * the whole document * [A] 1-64,66-68 [I] 71-73 DOI: http://dx.doi.org/10.1101/gr.161638.113 | [XAI] - XIANGJUN HE ET AL, "Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair", NUCLEIC ACIDS RESEARCH, (20160204), vol. 44, no. 9, doi:10.1093/nar/gkw064, ISSN 0305-1048, pages e85 - e85, XP055415869 [X] 65,69,70 * figure 2 * * the whole document * [A] 1-64,66-68 [I] 71-73 DOI: http://dx.doi.org/10.1093/nar/gkw064 | [XAI] - CHEN SIDI ET AL, "Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis", CELL, ELSEVIER, AMSTERDAM, NL, (20150305), vol. 160, no. 6, doi:10.1016/J.CELL.2015.02.038, ISSN 0092-8674, pages 1246 - 1260, XP029203797 [X] 65 * figure 5 * * the whole document * [A] 1-64,69-73 [I] 65-68 DOI: http://dx.doi.org/10.1016/j.cell.2015.02.038 | [A] - R. SHARMA ET AL, "In vivo genome editing of the albumin locus as a platform for protein replacement therapy", BLOOD, US, (20151008), vol. 126, no. 15, doi:10.1182/blood-2014-12-615492, ISSN 0006-4971, pages 1777 - 1784, XP055354026 [A] 1-73 * the whole document * DOI: http://dx.doi.org/10.1182/blood-2014-12-615492 | par le demandeur | US2014068797 | WO2013176772 | US5034506 | US3687808 | US4469863 | US4476301 | US5023243 | US5177196 | US5188897 | US5264423 | US5276019 | US5278302 | US5286717 | US5321131 | US5399676 | US5405939 | US5453496 | US5455233 | US5466677 | US5476925 | US5519126 | US5536821 | US5541306 | US5550111 | US5563253 | US5571799 | US5587361 | US5625050 | US5166315 | US5185444 | US5214134 | US5216141 | US5235033 | US5264562 | US5264564 | US5405938 | US5434257 | US5470967 | US5489677 | US5541307 | US5561225 | US5596086 | US5602240 | US5610289 | US5608046 | US5618704 | US5623070 | US5663312 | US5633360 | US5677437 | US5677439 | US5539082 | US5714331 | US5719262 | US4845205 | US5130302 | US5134066 | US5175273 | US5367066 | US5432272 | US5457187 | US5459255 | US5484908 | US5502177 | US5525711 | US5552540 | US5587469 | US5596091 | US5614617 | US5681941 | US5750692 | US5763588 | US5830653 | US6005096 | US2003158403 | US4828979 | US4948882 | US5218105 | US5525465 | US5541313 | US5545730 | US5552538 | US5578717 | US5580731 | US5591584 | US5109124 | US5118802 | US5138045 | US5414077 | US5486603 | US5512439 | US5578718 | US4587044 | US4605735 | US4667025 | US4762779 | US4789737 | US4824941 | US4835263 | US4876335 | US4904582 | US4958013 | US5082830 | US5112963 | US5214136 | US5245022 | US5254469 | US5258506 | US5262536 | US5272250 | US5292873 | US5317098 | US5371241 | US5391723 | US5416203 | US5451463 | US5510475 | US5512667 | US5514785 | US5565552 | US5567810 | US5574142 | US5585481 | US5587371 | US5595726 | US5597696 | US5599923 | US5599928 | US5688941 | US6287860 | WO0183692 | US5173414 | WO9513365 | US5658776 | WO9513392 | WO9617947 | WO9709441 | WO9708298 | WO9721825 | WO9706243 | WO9911764 | US5786211 | US5871982 | US6258595 | - GRIMM et al., J Virol, vol. 80, pages 426 - 439 | - COLELLA et al., Mol Ther Methods Clin Dev, (20180000), vol. 8, pages 87 - 104 | - "Gene Expression Technology", GOEDDEL, Methods in Enzymology, Academic Press, (19900000), vol. 185 | - JINEK et al., Science, (20120000), vol. 337, no. 6096, pages 816 - 821 | - Science, (20120000), vol. 337, no. 6096, pages 816 - 821 | - JINEK et al., Science, (20120000), vol. 337, pages 816 - 821 | - DELTCHEVA et al., Nature, (20110000), vol. 471, pages 602 - 607 | - MA, H. et al., Molecular Therapy - Nucleic Acids, (20140000), vol. 3, page el61 | - SAPRANAUSKAS et al., Nucleic Acids Res, (20110000), vol. 39, no. 21, pages 9275 - 9282 | - Nature Biotechnology, (20140000), vol. 32, pages 347 - 355 | - FONFARA et al., Nucleic Acids Research, (20140000), vol. 42, pages 2577 - 2590 | - NATHWANI AC, GRAY JT, NG CY et al., Blood., (20060000), vol. 107, no. 7, pages 2653 - 2661 | - WARD NJ; BUCKLEY SM; WADDINGTON SN et al., Blood., (20110000), vol. 117, no. 3, pages 798 - 807 | - RADCLIFFE PA; SION CJ; WILKES FJ et al., Gene Ther., (20080000), vol. 15, no. 4, pages 289 - 297 | - GAO et al., Nucleic Acids Research, (20080000), vol. 36, pages 2257 - 2267 | - COLGAN et al., Genes Dev., (19970000), vol. 11, pages 2755 - 2766 | - LEVITT N et al., Genes Dev, (19890000), vol. 3, no. 7, pages 1019 - 1025 | - NAKAI et al., J Virol, (20010000), vol. 75, pages 6969 - 6976 | - CRISTEA et al., Biotechnol Bioeng, (20130000), vol. 110, pages 871 - 880 | - SUZUKI et al., Nature, (20170000), vol. 540, pages 144 - 149 | - DE MESMAEKER et al., Ace. Chem. Res., (19950000), vol. 28, pages 366 - 374 | - NIELSEN et al., Science, (19910000), vol. 254, page 1497 | - BRAASCH; DAVID COREY, Biochemistry, (20020000), vol. 41, no. 14, pages 4503 - 4510 | - Heasman, Dev. Biol, (20020000), vol. 243, pages 209 - 214 | - NASEVICIUS et al., Nat. Genet., (20000000), vol. 26, pages 216 - 220 | - LACERRA et al., Proc. Natl. Acad. Sci., (20000000), vol. 97, pages 9591 - 9596 | - WANG et al., J. Am. Chem. Soc., (20000000), vol. 122, pages 8595 - 8602 | - MARTIN et al., Helv Chim Acta, (19950000), vol. 78, page 486 | - NIELSEN et al., Science, (19910000), vol. 254, pages 1497 - 1500 | - KORNBERG, A., DNA Replication, W. H. Freeman & Co., (19800000), pages 75 - 77 | - GEBEYEHU et al., Nucl Acids Res., (19970000), vol. 15, page 4513 | - SANGHVI, Y. S., Antisense Research and Applications, CRC Press, (19930000), pages 276 - 278 | - The Concise Encyclopedia of Polymer Science And Engineering, John Wiley & Sons, (19900000), pages 858 - 859 | - ENGLISCH et al., Angewandle Chemie, International Edition, (19910000), vol. 30, page 613 | - SANGHVI, Y. S., Antisense Research and Applications, CRC Press, (19930000), pages 289 - 302 | - Antisense Research and Applications, CRC Press, (19930000), pages 276 - 278 | - LETSINGER et al., Proc. Natl. Acad. Sci. USA, (19890000), vol. 86, pages 6553 - 6556 | - MANOHARAN et al., Bioorg. Med. Chem. Let., (19940000), vol. 4, pages 1053 - 1060 | - MANOHARAN et al., Ann. N. Y. Acad. Sci., (19920000), vol. 660, pages 306 - 309 | - MANOHARAN et al., Bioorg. Med. Chem. Let., (19930000), vol. 3, pages 2765 - 2770 | - OBERHAUSER et al., Nucl. Acids Res., (19920000), vol. 20, pages 533 - 538 | - KABANOV et al., FEBS Lett., (19900000), vol. 259, pages 327 - 330 | - SVINARCHUK et al., Biochimie, (19930000), vol. 75, pages 49 - 54 | - MANOHARAN et al., Tetrahedron Lett., (19950000), vol. 36, pages 3651 - 3654 | - SHEA et al., Nucl. Acids Res., (19900000), vol. 18, pages 3777 - 3783 | - MANCHARAN et al., Nucleosides & Nucleotides, (19950000), vol. 14, pages 969 - 973 | - MISHRA et al., Biochim. Biophys. Acta, (19950000), vol. 1264, pages 229 - 237 | - CROOKE et al., J. Pharmacol. Exp. Ther., (19960000), vol. 277, pages 923 - 937 | - HU et al., Protein Pept Lett., (20140000), vol. 21, no. 10, pages 1025 - 30 | - KORMANN et al., Nature Biotechnology, (20110000), vol. 29, pages 154 - 157 | - WARREN et al., Cell Stem Cell, (20100000), vol. 7, no. 5, pages 618 - 30 | - ANGART et al., Pharmaceuticals (Basel, (20130000), vol. 6, no. 4, pages 440 - 468 | - KANASTY et al., Molecular Therapy, (20120000), vol. 20, no. 3, pages 513 - 524 | - BURNETT et al., Biotechnol J., (20110000), vol. 6, no. 9, pages 1130 - 46 | - JUDGE; MACLACHLAN, Hum Gene Ther, (20080000), vol. 19, no. 2, pages 111 - 24 | - WHITEHEAD KA et al., Annual Review of Chemical and Biomolecular Engineering, (20110000), vol. 2, pages 77 - 96 | - GAGLIONE; MESSERE, Mini Rev Med Chem, (20100000), vol. 10, no. 7, pages 578 - 95 | - CHERNOLOVSKAYA et al., Curr Opin Mol Ther., (20100000), vol. 12, no. 2, pages 158 - 67 | - BEHLKE, Oligonucleotides, (20080000), vol. 18, no. 4, pages 305 - 19 | - FUCINI et al., Nucleic Acid Ther, (20120000), vol. 22, no. 3, pages 205 - 210 | - BREMSEN et al., Front Genet, (20120000), vol. 3, page 154 | - KOLE, Nature Reviews Drug Discovery, (20120000), vol. 11, pages 125 - 140 | - SOUTSCHEK et al., Nature, (20040000), vol. 432, pages 173 - 178 | - VOLKOV, Oligonucleotides, (20090000), vol. 19, pages 191 - 202 | - JUDGE et al., Mol. Ther., (20060000), vol. 13, pages 494 - 505 | - CEKAITE et al., J. Mol. Biol., (20070000), vol. 365, pages 90 - 108 | - KARIKO, K. et al., Immunity, (20050000), vol. 23, pages 165 - 175 | - WINKLER, Ther. Deliv., (20130000), vol. 4, pages 791 - 809 | - PEER; LIEBERMAN, Gene Therapy, (20110000), vol. 18, pages 1127 - 1133 | - LOVE et al., PNAS, (20100000), vol. 107, pages 1864 - 1869 | - SAMULSKI et al., Proc. Natl. Acad. S6. USA, (19820000), vol. 79, pages 2077 - 2081 | - LAUGHLIN et al., Gene, (19830000), vol. 23, pages 65 - 73 | - SENAPATHY; CARTER, J. Biol. Chem., (19840000), vol. 259, pages 4661 - 4666 | - CARTER, Current Opinions in Biotechnology, (19920000), pages 1533 - 539 | - MUZYCZKA, Curr. Topics in Microbial. and Immunol., (19920000), vol. 158, pages 97 - 129 | - RATSCHIN et al., Mol. Cell. Biol., (19840000), vol. 4, page 2072 | - HERMONAT et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, page 6466 | - TRATSCHIN et al., Mol. Cell. Biol., (19850000), vol. 5, page 3251 | - MCLAUGHLIN et al., J. Virol., (19880000), vol. 62, page 1963 | - LEBKOWSKI et al., Mol. Cell. Biol., (19880000), vol. 7, page 349 | - SAMULSKI et al., J. Virol., (19890000), vol. 63, pages 3822 - 3828 | - PERRIN et al., Vaccine, (19950000), vol. 13, pages 1244 - 1250 | - PAUL et al., Human Gene Therapy, (19930000), vol. 4, pages 609 - 615 | - CLARK et al., Gene Therapy, (19960000), vol. 3, pages 1124 - 1132 | - SEGAL et al., Proc Natl Acad Sci USA, (19990000), vol. 96, no. 6, pages 2758 - 63 | - DREIER B et al., J Mol Biol., (20000000), vol. 303, no. 4, pages 489 - 502 | - LIU Q et al., J Biol Chem., (20020000), vol. 277, no. 6, pages 3850 - 6 | - DREIER et al., J Biol Chem, (20050000), vol. 280, no. 42, pages 35588 - 97 | - DREIER et al., J Biol Chem., (20010000), vol. 276, no. 31, pages 29466 - 78 | - BOCH, Science, (20090000), vol. 326, no. 5959, pages 1509 - 12 | - MAK et al., Science, (20120000), vol. 335, no. 6069, pages 716 - 9 | - MOSCOU et al., Science, (20090000), vol. 326, no. 5959, page 1501 | - CERMAK et al., Nucleic Acids Res., (20110000), vol. 39, no. 12, page 82 | - LI et al., Nucleic Acids Res., (20110000), vol. 39, no. 14, pages 6315 - 25 | - WEBER et al., PLoS One., (20110000), vol. 6, no. 2, page el6765 | - WANG et al., J Genet Genomics, (20140000), vol. 41, no. 6, pages 339 - 47 | - CERMAK T et al., Methods Mol Biol., (20150000), vol. 1239, pages 133 - 59 | - STEENTOFT et al., Glycobiology, (20140000), vol. 24, no. 8, pages 663 - 80 | - BELFORT; BONOCORA, Methods Mol Biol., (20140000), vol. 1123, pages 1 - 26 | - HAFEZ; HAUSNER, Genome, (20120000), vol. 55, no. 8, pages 553 - 69 | - BOISSEL et al., NAR, (20140000), vol. 42, pages 2591 - 2601 | - KLEINSTIVER et al., G3, (20140000), vol. 4, pages 1155 - 65 | - BOISSEL; SCHARENBERG, Methods Mol. Biol., (20150000), vol. 1239, pages 171 - 96 | - WOLFS et al., NAR, (20140000), vol. 42, pages 8816 - 29 | - TSAI et al., Nature Biotech, (20140000), vol. 32, pages 569 - 76 | - GUILINGER et al., Nature Biotech., (20140000), vol. 32, pages 577 - 82 | - STEMMER M; THUMBERGER T; DEL SOL KEYER M; WITTBRODT J; MATEO JL, "CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool", PLoS ONE, vol. 10, no. 4, (20150000), page e0124633, URL: https://doi.org/10.1371/journal.pone.0124633 | - BRINKMAN et al., Nucleic Acids Research, vol. 42, page 168 | - SUZUKI et al., Nature, (20160000), vol. 540, page l44 | - AUER, T. O. et al., Genome research, (20140000), vol. 24, no. 1, pages 142 - 153 | - MAO, Z. et al., Cell cycle, (20080000), vol. 7, no. 18, pages 2902 - 2906 | - MARESCA, M. et al., Genome research, (20130000), vol. 23, no. 3, pages 539 - 546 | - CRISTEA, S. et al., Biotechnology and bioengineering, (20130000), vol. 110, no. 3, pages 871 - 880 | - STEMMER, M. et al., PloS One, (20150000), vol. 10, no. 4, page e0124633 | - BRINKMAN, E. K.; CHEN, T.; AMENDOLA, M.; VAN STEENSEL, B., Nucleic acids research, (20140000), vol. 42, no. 22, pages el68 - el68 | - ANDERSON et al., Journal of Biotechnology, (20150000), vol. 211, pages 56 - 65 | - LOVE, K. T.; MAHON, K. P.; LEVINS, C. G.; WHITEHEAD, K. A.; QUERBES, W.; DORKIN, J. R.; FRANK-KAMENETSKY, M., Proceedings of the National Academy of Sciences, (20100000), vol. 107, no. 5, pages 1864 - 1869 | - COPPOLA et al., J Blood Med., (20100000), vol. 1, pages 183 - 195 | - LEVITT et al., GENES & DEVELOPMENT, (19890000), vol. 3, pages 1019 - 1025 | - BI L; LAWLER AM; ANTONARAKIS SE; HIGH KA; GEARHART JD; KAZAZIAN HH JR., Nat Genet, (19950000), vol. 10, no. 1, pages 119 - 21 | - MCINTOSH, J. et al., Blood, (20130000), vol. 121, pages 3335 - 44 | - QUAN, P. L. et al., Sensors, (20180000), vol. 18, page 1271 | - TSAI et al., Nat Biotechnol, (20150200), vol. 33, no. 2, pages 187 - 197 | - CHIP-SEQ, Nature Biotechnology, (20140000), vol. 32, pages 677 - 683 | - TSAI et al., Nature Biotech, (20150000), vol. 33, pages 187 - 197 | - BRINKMAN et al., Nucleic Acids Research, (20140000), vol. 1 | - Levitt Int J Gen Med, vol. 9, pages 229 - 255 | - OSWALD et al., Am J Med Technol., (19830000), vol. 49, pages 57 - 59 | - WANG et al., Nat Rev Genet., (20090000), vol. 10, pages 57 - 63 | - FAGERBERG et al., Mol Cell Proteomics., (20140200), vol. 13, no. 2, pages 397 - 406 | - ZAIAS et al., J American Association for Laboratory Animal Science, vol. 48, pages 387 - 390 | - MACHLUS et al., Blood, (20110000), vol. 117, pages 4953 - 4963 | WO1992US09196 | WO1998US18600 | WO1996US14423 | WO1996US13872 | WO1996US20777 | WO1996FR01064 |